
    
      Ten patients from both genders diagnosed with Knee osteoarthrosis, will be enrolled according
      to strict inclusion and exclusion criteria. These patients will be injected with Wharton
      Jelly derived Mesenchymal Stem Cells. Then, they are followed by clinical assessment,
      laboratory investigations as well as magnetic resonance imaging (MRI) of the injected knee.
    
  